{"id":"https://openalex.org/W1997655511","doi":"https://doi.org/10.1016/j.bmcl.2012.10.074","title":"Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat","display_name":"Discovery of a novel non-steroidal GR antagonist with in vivo efficacy in the olanzapine-induced weight gain model in the rat","publication_year":2012,"publication_date":"2012-10-23","ids":{"openalex":"https://openalex.org/W1997655511","doi":"https://doi.org/10.1016/j.bmcl.2012.10.074","mag":"1997655511","pmid":"https://pubmed.ncbi.nlm.nih.gov/23131342"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2012.10.074","doi":"https://doi.org/10.1016/j.bmcl.2012.10.074","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2012.10.074","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010207048","display_name":"Hazel Hunt","orcid":"https://orcid.org/0000-0002-4316-1301","observed_orcids":["https://orcid.org/0000-0002-4316-1301"]},"institutions":[{"id":"https://openalex.org/I4210132782","display_name":"Corcept Therapeutics (United States)","ror":"https://ror.org/03ey3qt70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132782"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hazel J. Hunt","raw_affiliation_strings":["Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA. hhunt@corcept.com","Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA. hhunt@corcept.com","institution_ids":["https://openalex.org/I4210132782"]},{"raw_affiliation_string":"Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA","institution_ids":["https://openalex.org/I4210132782"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051557527","display_name":"Nicholas C. Ray","orcid":"https://orcid.org/0000-0001-9889-9365","observed_orcids":["https://orcid.org/0000-0001-9889-9365"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas C. Ray","raw_affiliation_strings":["Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"George Hynd","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Hynd","raw_affiliation_strings":["Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065513683","display_name":"J.D. Sutton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jon Sutton","raw_affiliation_strings":["Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065608439","display_name":"Mohammed Sajad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohammed Sajad","raw_affiliation_strings":["Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101601172","display_name":"Elizabeth O\u2019Connor","orcid":"https://orcid.org/0000-0003-0571-0768","observed_orcids":["https://orcid.org/0000-0003-0571-0768"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth O\u2019Connor","raw_affiliation_strings":["Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007303841","display_name":"Shahadat Ahmed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shahadat Ahmed","raw_affiliation_strings":["Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111654525","display_name":"Peter M. Lockey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Lockey","raw_affiliation_strings":["Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Steve Daly","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steve Daly","raw_affiliation_strings":["Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019684435","display_name":"Gerry Buckley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerry Buckley","raw_affiliation_strings":["Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex, CM19 5TR, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037782599","display_name":"Robin Dawn Clark","orcid":"https://orcid.org/0000-0002-7277-4975","observed_orcids":["https://orcid.org/0000-0002-7277-4975"]},"institutions":[{"id":"https://openalex.org/I4210132782","display_name":"Corcept Therapeutics (United States)","ror":"https://ror.org/03ey3qt70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132782"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin D. Clark","raw_affiliation_strings":["Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA","institution_ids":["https://openalex.org/I4210132782"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004850508","display_name":"Robert L. Roe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132782","display_name":"Corcept Therapeutics (United States)","ror":"https://ror.org/03ey3qt70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132782"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Roe","raw_affiliation_strings":["Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA","institution_ids":["https://openalex.org/I4210132782"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025170450","display_name":"Christine M. Blasey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132782","display_name":"Corcept Therapeutics (United States)","ror":"https://ror.org/03ey3qt70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132782"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine Blasey","raw_affiliation_strings":["Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA","institution_ids":["https://openalex.org/I4210132782"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044072489","display_name":"Joe Belanoff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132782","display_name":"Corcept Therapeutics (United States)","ror":"https://ror.org/03ey3qt70","country_code":"US","type":"company","lineage":["https://openalex.org/I4210132782"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joe Belanoff","raw_affiliation_strings":["Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Corcept Therapeutics, 149 Commonwealth Drive, Menlo Park, CA 94025, USA","institution_ids":["https://openalex.org/I4210132782"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5010207048"],"corresponding_institution_ids":["https://openalex.org/I4210132782"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.1238,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.45076312,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"22","issue":"24","first_page":"7376","last_page":"7380"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.6563000082969666,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10489","display_name":"Regulation of Appetite and Obesity","score":0.6563000082969666,"subfield":{"id":"https://openalex.org/subfields/2807","display_name":"Endocrine and Autonomic Systems"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.05719999969005585,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.05389999970793724,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucocorticoid-receptor-antagonist","display_name":"glucocorticoid receptor antagonist","score":0.9269999861717224},{"id":"https://openalex.org/keywords/antipsychotic-induced-weight-gain","display_name":"antipsychotic-induced weight gain","score":0.8410000205039978},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.40700000524520874},{"id":"https://openalex.org/keywords/structure-activity-optimization","display_name":"structure-activity optimization","score":0.8289999961853027},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8329949378967285},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8173351287841797},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.7957529425621033},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7336248159408569},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6150804162025452},{"id":"https://openalex.org/C2780320433","wikidata":"https://www.wikidata.org/wiki/Q3403879","display_name":"Weight gain","level":3,"score":0.5199590921401978},{"id":"https://openalex.org/C2781353949","wikidata":"https://www.wikidata.org/wiki/Q3271533","display_name":"Dopamine antagonist","level":4,"score":0.47424760460853577},{"id":"https://openalex.org/C3017990168","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Orally active","level":3,"score":0.41519150137901306},{"id":"https://openalex.org/C147583825","wikidata":"https://www.wikidata.org/wiki/Q620876","display_name":"Body weight","level":2,"score":0.3423672914505005},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.31604576110839844},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3032596707344055},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2294788956642151},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.16247302293777466},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.08323052525520325},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07355397939682007},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.06971675157546997},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011965","descriptor_name":"Receptors, Glucocorticoid","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013941","descriptor_name":"Thymine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013941","descriptor_name":"Thymine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D013941","descriptor_name":"Thymine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013941","descriptor_name":"Thymine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015430","descriptor_name":"Weight Gain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023421","descriptor_name":"Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2012.10.074","doi":"https://doi.org/10.1016/j.bmcl.2012.10.074","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2012.10.074","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:23131342","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23131342","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1983119991","https://openalex.org/W1998817848","https://openalex.org/W2008782804","https://openalex.org/W2027771930","https://openalex.org/W2032957128","https://openalex.org/W2055203668","https://openalex.org/W2058212311"],"related_works":["https://openalex.org/W1983119991","https://openalex.org/W2095690365","https://openalex.org/W1998817848","https://openalex.org/W1980050063","https://openalex.org/W2950228929","https://openalex.org/W2053380341","https://openalex.org/W1968782507","https://openalex.org/W7099523821","https://openalex.org/W1437455310","https://openalex.org/W2602462061"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}